← Open Payments lookup

KYLE WARD: Open Payments

NPI 1124548995 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$695 in 35 payments from 10 companies in 2025. Trend: 2023 $378 · 2024 $578 · 2025 $695

Food & beverage: $695
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.9$167
Janssen Pharmaceuticals, Inc5$128
E.R. Squibb & Sons, L.L.C.5$93
Teva Pharmaceuticals USA, Inc.5$85
Otsuka America Pharmaceutical, Inc.3$56
Lundbeck LLC3$56
Vanda Pharmaceuticals Inc.2$46
Axsome Therapeutics, Inc.1$23
Alkermes, Inc.1$21
Tris Pharma Inc1$19

Products named: INGREZZA, COBENFY, REXULTI, INVEGA SUSTENNA, SPRAVATO, UZEDY, AUSTEDO XR, FANAPT.

Industry payments across MD — which companies pay providers there.